PSA HealthCare Announces Agreement to Acquire Americare At Home's Pediatric Nursing Business
2006年11月28日 - 6:45AM
ビジネスワイヤ(英語)
Pediatric Services of America, Inc., d/b/a PSA Healthcare (Nasdaq:
PSAI) announced today that it has signed an Agreement to acquire
certain of the assets of Americare At Home, Inc. a Massachusetts
corporation (�Americare�). The acquisition will include certain of
Americare�s pediatric nursing locations in the Shrewsbury and
Newton, Massachusetts markets. The purchase price is approximately
$1.4 million in cash with Americare retaining its accounts
receivable. Americare�s annualized net pediatric revenue, all of
which is being acquired by PSA, totals approximately $2.7 million.
We expect the closing date of the transaction to occur in January
2007. �We are excited to further expand our presence in the
Massachusetts market through this acquisition,� said Daniel J.
Kohl, President and CEO of PSA. �We continue to evaluate a number
of opportunities available in attractive markets and remain focused
on executing our acquisition strategy within the private duty
nursing segment.� PSA provides comprehensive pediatric home health
care services through a network of 54 branch offices in 18 states,
including satellite offices and branch office start-ups. Through
these offices PSA provides a combination of services, including
pediatric private duty nursing (PDN) and pediatric day treatment
centers (PPECs). Additional information on PSAI may be found on the
Company's website at http://www.psahealthcare.com. NOTE: This press
release contains certain forward-looking statements (as such term
is defined in the Private Securities Litigation Reform Act of 1995)
relating to future financial performance of Pediatric Services of
America, Inc. (the �Company�). When used in this press release, the
words �may,� �targets,� �goal,� �could,� �should,� �would,�
�believe,� �feel,� �expects,� �confident,� �anticipate,�
�estimate,� �intend,� �plan,� �potential� and similar expressions
may be indicative of forward-looking statements. These statements
by their nature involve substantial risks and uncertainties,
certain of which are beyond the Company�s control. The Company
cautions that various factors, including the factors described
hereunder and those discussed in the Company�s other filings with
the Securities and Exchange Commission, as well as general economic
conditions, industry trends, the Company's anticipated uses of the
proceeds from the sale of its Respiratory and Pharmacy Businesses,
the Company's ability to assimilate and manage previously acquired
field operations, collect accounts receivable, including
receivables related to acquired businesses and receivables under
appeal, hire and retain qualified personnel and comply with and
respond to billing requirements issues, including those related to
the Company�s billing and collection system, nurse shortages,
competitive bidding, HIPAA regulations, adverse litigation,
workers� compensation losses, availability and cost of medical
malpractice insurance and any potential reduced state funding
levels and nursing hours authorized by Medicaid program, could
cause actual results or outcomes to differ materially from those
expressed in any forward-looking statements of the Company made by
or on behalf of the Company. Any forward-looking statement speaks
only as of the date on which such statement is made, and the
Company undertakes no obligation to update any forward-looking
statement or statements to reflect events or circumstances after
the date on which such statement is made or to reflect the
occurrence of an unanticipated event. New factors emerge from time
to time, and it is not possible for management to predict all of
such factors. Further, management cannot assess the impact of each
such factor on the business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements.
Pediatric Services of America, Inc., d/b/a PSA Healthcare (Nasdaq:
PSAI) announced today that it has signed an Agreement to acquire
certain of the assets of Americare At Home, Inc. a Massachusetts
corporation ("Americare"). The acquisition will include certain of
Americare's pediatric nursing locations in the Shrewsbury and
Newton, Massachusetts markets. The purchase price is approximately
$1.4 million in cash with Americare retaining its accounts
receivable. Americare's annualized net pediatric revenue, all of
which is being acquired by PSA, totals approximately $2.7 million.
We expect the closing date of the transaction to occur in January
2007. "We are excited to further expand our presence in the
Massachusetts market through this acquisition," said Daniel J.
Kohl, President and CEO of PSA. "We continue to evaluate a number
of opportunities available in attractive markets and remain focused
on executing our acquisition strategy within the private duty
nursing segment." PSA provides comprehensive pediatric home health
care services through a network of 54 branch offices in 18 states,
including satellite offices and branch office start-ups. Through
these offices PSA provides a combination of services, including
pediatric private duty nursing (PDN) and pediatric day treatment
centers (PPECs). Additional information on PSAI may be found on the
Company's website at http://www.psahealthcare.com. NOTE: This press
release contains certain forward-looking statements (as such term
is defined in the Private Securities Litigation Reform Act of 1995)
relating to future financial performance of Pediatric Services of
America, Inc. (the "Company"). When used in this press release, the
words "may," "targets," "goal," "could," "should," "would,"
"believe," "feel," "expects," "confident," "anticipate,"
"estimate," "intend," "plan," "potential" and similar expressions
may be indicative of forward-looking statements. These statements
by their nature involve substantial risks and uncertainties,
certain of which are beyond the Company's control. The Company
cautions that various factors, including the factors described
hereunder and those discussed in the Company's other filings with
the Securities and Exchange Commission, as well as general economic
conditions, industry trends, the Company's anticipated uses of the
proceeds from the sale of its Respiratory and Pharmacy Businesses,
the Company's ability to assimilate and manage previously acquired
field operations, collect accounts receivable, including
receivables related to acquired businesses and receivables under
appeal, hire and retain qualified personnel and comply with and
respond to billing requirements issues, including those related to
the Company's billing and collection system, nurse shortages,
competitive bidding, HIPAA regulations, adverse litigation,
workers' compensation losses, availability and cost of medical
malpractice insurance and any potential reduced state funding
levels and nursing hours authorized by Medicaid program, could
cause actual results or outcomes to differ materially from those
expressed in any forward-looking statements of the Company made by
or on behalf of the Company. Any forward-looking statement speaks
only as of the date on which such statement is made, and the
Company undertakes no obligation to update any forward-looking
statement or statements to reflect events or circumstances after
the date on which such statement is made or to reflect the
occurrence of an unanticipated event. New factors emerge from time
to time, and it is not possible for management to predict all of
such factors. Further, management cannot assess the impact of each
such factor on the business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements.
Pediatric Services OF America (NASDAQ:PSAI)
過去 株価チャート
から 8 2024 まで 9 2024
Pediatric Services OF America (NASDAQ:PSAI)
過去 株価チャート
から 9 2023 まで 9 2024